[S18★☆] Recent trends and future perspectives for non-clinical pharmacokinetics and safety evaluation of therapeutic monoclonal antibodies —at the dawn of a new era

2:45 PM - 3:10 PM JST(5:45 AM - 6:10 AM UTC)

[S18-5] The Current Status of Nonclinical Safety Evaluation of Antibody Therapeutics

○Mutsumi Suzuki^1,2 (1. Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA, 2. TR Labs, Kyowa Kirin)